(Q48316330)

10 February 2018

review article

1 reference

title

Diagnosis and management of tuberous sclerosis complex (English)

1 reference

10 February 2018

1 reference

Franz DN

1

1 reference

10 February 2018

publication date

1 December 1998

1 reference

10 February 2018

Seminars in pediatric neurology

published in

1 reference

10 February 2018

volume

5

1 reference

10 February 2018

issue

4

1 reference

10 February 2018

page(s)

253-268

1 reference

10 February 2018

Clinical, neuropathological and genetic aspects of the tuberous sclerosis complex.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Annotation: tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Identification and characterization of the tuberous sclerosis gene on chromosome 16

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Loss of tuberin from cerebral tissues with tuberous sclerosis and astrocytoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Expression of the tuberous sclerosis 2 gene product, tuberin, in adult and developing nervous system tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Female germline mosaicism in tuberous sclerosis confirmed by molecular genetic analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Cortical tuber count: a biomarker indicating neurologic severity of tuberous sclerosis complex

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Cortical and subcortical tubers in tuberous sclerosis and FLAIR sequence

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Neurocutaneous syndromes associated with pigmentary skin lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Cardiac rhabdomyomas and their association with tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Diagnosis and management of fetal cardiac tumors: a multicenter experience and review of published reports

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Ventricular tachycardia caused by cardiac rhabdomyoma in a young adult with tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Ophthalmic manifestations of tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Rare pulmonary manifestations of tuberous sclerosis in children.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Lung transplantation for lymphangioleiomyomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Incidence of hepatic hamartomas in tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Developmental enamel defects in tuberous sclerosis: a clinical genetic marker?

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Pitted enamel hypoplasia in tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Tuberous sclerosis in old age

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Bone changes in tuberous sclerosis mimicking metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Diagnostic criteria: tuberous sclerosis complex. Report of the Diagnostic Criteria Committee of the National Tuberous Sclerosis Association

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Diagnosis of tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Phenotypes of the tuberous sclerosis complex with a revision of diagnostic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Neurological manifestations of tuberous sclerosis complex

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Vigabatrin for refractory partial seizures in children with tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Frontal lobe epilepsy associated with tuberous sclerosis: electroencephalographic-magnetic resonance image fusioning.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Epilepsies with partial seizures in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Lamotrigine in absence and primary generalized epilepsies

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Surgical management and seizure outcome in patients with tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Surgical treatment for epilepsy in cerebral tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Autism and epilepsy (and tuberous sclerosis?) in two pre-adolescent boys: neuropsychiatric aspects before and after epilepsy surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Development, behaviour and seizures in 300 cases of tuberous sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Tuberous sclerosis: function follows form

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

A prevalence study of autism in tuberous sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Autism and psychiatric disorders in tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Autistic behaviour and attention deficits in tuberous sclerosis: a population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Association of tuberous sclerosis of temporal lobes with autism and atypical autism

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

Sleep disorders in tuberous sclerosis: a polysomnographic study.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

The treatment of sleep disorders with melatonin.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9091%2898%2980004-1

7 January 2021

10.1016/S1071-9091(98)80004-1

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018